Medicinal plants, since times immemorial, have been used in virtually all cultures as a source of medicine. The widespread use of herbal remedies and healthcare preparations, as those described in ancient texts such as the Vedas and the bible, and obtained form commonly used traditional herbs and medicinal plants, has been traced to the occurance of natural products with medicinal properties
The use of traditional medicine and medicinal plants in most developing countries, as a normative basis for the maintenance of good health, has been widely observed (UNESCO, 1996) . Furthermore, an increasing reliance on the use of medicinal plants in the industrialized societies has been traced to the extraction and development of several drugs and chemotherapeutics form these plants as well as form traditionally used rural herbal remedies (UNESCO, 1998) Moreover, in these societies, herbal remedies have become more popular in the treatment of minor ailments, and also on account of the increasing costs of personal health maintenance, indeed the market and public demand has been so great that there is a great risk that many medicinal plants, today, face either extinction or loss of genetic diversity.
Background
Medicine, in several developing countries, using local traditions and beliefs, is still the mainstay of health care. As defined by WHO , health is a state of complete physical, mental, and social well being and not merely the absence of disease or infirmity.
The practice of traditional medicine is widespread is china, India, Japan, Pakistan, Sri Lanka and Thailand.
In china about 40% of the total medicinal consumption is attributed to traditional tribal medicines. In Thailand, herbal medicines make use of legumes encountered in the caesalpiniaceae, the fabaceae, and the Mimosaceae. In the mid-90s, it is estimated that receipts of more than US$2.5 billion have resulted form the sales of herbal medicines. And, in Japan, Herbal medicinal preparation are more in demand than mainstream pharmaceutical products.
Africa is a rich source of medicinal plants perhaps, the best known species is phytolacca dodecandra.
Extracts of the plant, commonly known as endod, are used as an effective mollucicide to control schistosomiasis (Lemma, 1991 
ISSUES:
Traditional and folklore medicine bequeathed from generation to generation is rich in domestic recipes and communal practice.
Encompassing concepts and methods for the protection and restoration of health, traditional medicine has served as a fount of alternative medicine, new pharmaceuticals, and healthcare products. The best known examples of traditional medicine, differing in concept and protocol, are well developed systems such as acupuncture and ayurvedic medicine that have been widely used to conserve human health in China and India.
Developed systems such as acupuncture and ayruvedic medicine that have been widely used to conserve human health in China and India.
Developed countries, in recent times, are turning to the use of traditional medicinal systems that involve the use of herbal drugs and remedies.
About 1400 herbal preparations are used widely, according to a recent survey in Member states of European Union. Herbal preparations are popular and are on significance in primary healthcare in Belgium, France, Germany and Netherlands, Such popularity of healthcare plant-derived products has been traced to their increasing acceptance and use in the consmetic indurey as well as to increasing public costs in the daily maintenance of personal health and well being. Examples of such beautyoriented therapeuticals are skin tissue regenerators, anti-wrinkling agents and anitage creams.
Most dernmaceuticals are derved from algal extracts that are rich in minerals and the vitamin B group.
Skincare products such as skin creams, skin tonics, etc. derived from medicinal plants are grouped together as dernaceuticals. Also amongst the poor, cures and drugs, derived from plants, constitute the main source of healthcare products.
Gorman (1992) drew attention to the power of Chinese folk medicnal potions in treating maladies from eczema and malaria to
Pages 281 -286 respiratory disorders. In the quest for new medicines to treat old and emergent diseases such as malaria and AIDS, attention is now being given to discovering the active ingredients encountered in the treasury of over 5,000 Chinese herbs, plants and roots that have been used routinely and traditionally. Quinghaosu and Chaihu are two such examples. Whereas the former, called artemisinin and obtained from Artemisia annua is expected to yield, in the coming millennium, a potent new class of antimalarials, the latter, obtained from Bupleurum Chinese and used as a popular remedy for hepatitis is the focus of intense research by the Japanese pharmaceutical industry. More recently, the biochemistry of tianhuafen or cucumber is being studied in the USA to decipher the identity of compound Q, an extract used in China and credited with remedial and relief properties in AIDS sufferers. Dietary supplements such as vitamin A in poultry feeds in Uganda are supplied through enrichments of amaranth (Amaranthus sp.) It is estimated that medicinal plants, for several centuries, have been widely used as a primary source prevention and control of livestock diseases. In fact, interest of such use in the veterinary sector has resulted primarily from the increasing cost of livestock maintenance and the introduction of new technology in the production of veterinary medicines and vaccines.
McGee (1998), Surveying the use of spice and their medicinal properties around the world, concluded that spices serve the adaptive pupose of reducing food-borne disease. In reviewing relevant texts ranging from the preservative properties of spices against food spoilage to the present of antimicrobial substances that lay claim to the elimination of pathogenic organisms in food preparations, the case is made for a more objective analysis and study of the medicinal properties of spices in victo rather than in victo. A whole range of plantderived dietary supplement s, phytochemicals and pro-vitamins that assist in maintaining good health and combating disease are now being described as functional foods, nutriceuticals and nutraceuticals. Table 1 that call for adherence to and observation of cultural and intellectual property rights have been addressed and enshrined in the chiangMai and Kari -Oca declarations ( Table 2 ). The first countries to seriously tackle these issues are china and India.
Indeed, programmes dealing with medicinal plant conservation, cultivation, community involvement and sustainable development being initiated elsewhere, could benefit immensely form the Chinese and Indian experiences (World Bank, 1997).
Genetic biodiversity of traditional medicinal herbs and plants is continuously under the threat of extinction as a result of growth exploitation, environment-unfriendly harvesting techniques, loss of growth habitats and unmonitored trade of medicinal plants.
Medicinal herbs, possessing penile potency properties and anti-cancer principles are the focus of smuggling to import markets in Germany, France, Switzerland, Japan, the U.K. and the U.S.A. The best known example, in recent times, is that of tetu lakda (Nothadoytes foetida). Commonly encountered in southern India and Sri lanka, the herb is exploited as a source of anticancer drugs.
On the other hand, Adonis vernalis, extinct in Italy and the Netherlands, is an endangered species in Germany, Slovakia, Sweden and Switzerland, Fortunately, to safeguard against such practices and losses, guidelines and licensing concerning the use of such plants are provided for in the convention on international Trade Endangered species of Wild Flora and Fauna (CITES).
The industrial uses of medicinal plants are many.
These range from traditional medicines, herbal teas, and health foods such as nutircuticals to galenicals, phytopharmaceuticals and industrially produced pharmaceuticals, Furthermore, medicinal plants constitute a source of valuable foreign exchange for most developing countries, as they are a ready source of drugs such as quinine and reserpine; galenicals like tinctures and of intermediates (e.g. diosgenin from Discorea Sp.) in the production of semi-synthetic drugs.
The world market for plant derived chemicals pharamaceuticals, fragrances, flavours, and colour ingredients, alone excess several billion dollars per year. Classic examples of phytochemicals in biology and medicine include taxol, vincristine, vinblastine, colchicines as well as the Chinese antimalarial-artemisinin, and the Indian ayurvedic drug-forkolin. Trade in medicinal plants is growing in volume and in exports. It is estimated that the global trade in medicinal plants is US $ 800 million per year. The botanical market, inclusive of herbs and medicinal plants, in the U.S.A. is estimated, at retail, at approximately US$ 1.6 billion p.a China with exports of over 120,000 tonnes p.a., and India with some 32,000 tonnes p.a dominate the international markets.
It is estimated that Europe, annually imports about 400,00 t of medicinal plants with an average market value of US$ 1 billion form Africa and Asia. A growing awareness of this new contributor to the foreign-exchange reserves of several national treasuries is beginning to emerge.
To satisfy growing market demands, surveys are being conducted to unearth new plant sources of herbal remedies and medicines.
In several industrialized societies, plantderived prescription drugs constitute and element in the maintenance of health.
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Medicinal plants are an integral component of research developments in the pharmaceutical industry.
Such research focuses on the isolation and direct use of active medicinal constitutents, or on the development of semi-synthetic drugs, or still again on the active screening of natural products to yield synthetic pharmacologically-active compounds. In Germany, for example, over 1500 plant species encountered in some 200 familes and 800 genera have been processed into medicnal products.
In South Africa, likewise, some 500 species are commercialized trade products.
Today, Bulgaria, Germany and Poland are recognized as major exporters of plant-based medicinal products.
The development and commercialization of medicinal plant-based bioindustries in the developing countries is dependent upon the availability of facilities and information concerning upstream and downstream bioprocessing, extraction, purification and marketing of the inductrial potential of medicinal plants.
Absence of such infrastructure compounded by lack of governmental interest and financial support restricts the evolution of traditional herbal extracts into authenticated market products. Furthermore the absencse of modernized socio-economic and public healthcare systems reinforce reliance of rural and lower-income urban populations on the use of traditional medicinal herbs and plants as complementary aids to routine pharamaceutical market products.
The prophylactic and therapeutic effects of plant foods and extracts in reducing cardiovascular disease has been reviewed (Walker, 1996) . Non-nutrient phytochemicals are increasingly being recognized as potential health promoters I reducing the risks of cardiovascular disearse and atherosclerosis.
Prominent herbs identified were Achillea millefolium (yarrow), Allium Sativum (garlic), Convallaria majalis (lily of the Valley), (hawthorn), Cynara scolymus (globe artichoke), Gingko biloba (gingko) and Viburnum opulus (cramp bark).
Saint-john's work known as Johanniskrant in German for centuries has been used to treat people with mild and moderate depreassion without the side effects of Prozac. Widely sold in Germany and other European countries, and awaiting official approval by the US food and Drug Administration, Saint-john's wort is being regarded as a serious rival to Prozac (Andrews, 1997 
CONCLUDING REMARKS
Recent and renewed interest in medicinal plants coupled to developments in information technology had fuelled an explosion in the range and content of electronic information concerning medicinal plants as a re-emergent health aid. Bhat (1997) recently reviewed diverse sources of such information in traditional adstracting services as well as in a variety of online electronic databases. As a result of such developments, access to indigenous people and cultures concerning medicinal plants are greatly facilitated. Furthermore, the active participation of such natural custodians and practitioners of valuable knowledge is guaranteed in the generation of research focusing on screening programmes dealing with the isolation of bioactive principles and the development of new drugs.
